Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 2,400,000
- 试验地点
- 1
- 主要终点
- Autism
研究概览
简要总结
The overall project aim is to study children's neurodevelopmental outcomes (including diagnoses of autism, ADHD, and intellectual disability) following exposure to maternal anemia during pregnancy or anemia during the first year of life using national and regional Swedish health-data registers, and to assess children's neurodevelopmental outcomes over the range of maternal hemoglobin levels during pregnancy.
详细描述
Our overall hypothesis is that early life iron sufficiency may promote appropriate neurodevelopment and reduce risk of neurodevelopmental disorders in children. We will use Swedish register data to define a cohort of maternal-child pairs to follow from gestation through childhood. We will consider exposure to anemia during two key time periods: gestation and the first year of life. Exposure data are recorded in Swedish medical records prospectively relative to the follow-up for the outcomes.
To assess exposure to maternal anemia, we will consider maternal diagnoses of anemia during pregnancy in a national cohort of maternal-child pairs, using ICD codes recorded in pregnancy in the Swedish National Patient Register and the Swedish Medical Birth Register. In a sub-sample of mother-child pairs in Stockholm with data available from antenatal records (i.e., Obstetrix register data), we will also collect data regarding levels of maternal hemoglobin measured longitudinally over the course of pregnancy, and consider this as a continuous variable and divided into categories to reflect the full range of potential exposures from very low to very high. We will consider whether risk of the outcomes associated with exposure to anemia or decreasing hemoglobin levels vary with the time of onset during pregnancy.
To assess exposure to anemia during the first year of life, we will consider infant's diagnoses of anemia during the first year of life in a national cohort of maternal-child pairs, using ICD codes recorded during the year after birth in the Swedish National Patient Register. We will consider whether risk of the outcomes associated with exposure to anemia during vary with the time of onset during the first year of life, and whether anemia during the first year interacts with gestational age at birth.
The main outcome measures will be incidence of children's diagnoses of any of three common neurodevelopmental conditions: autism, attention-deficit/hyperactivity disorder (ADHD), and intellectual disability. Diagnoses will be ascertained using ICD codes recorded in pregnancy in the Swedish National Patient Register. For the sub-sample of mother-child pairs for children born in Stockholm, we will also ascertain outcomes in regional registers that capture further sources of outpatient treatment and care, primarily the VAL database. Secondary analyses will consider the incidence of commonly co-occurring combinations of the disorders (e.g., autism with co-occurring intellectual disability).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •children born in Sweden from January 1, 1987 to December 31, 2010 (national cohort)
- •children born in Region Stockholm from January 1, 2007 to December 31, 2010 (Stockholm regional cohort)
排除标准
- •Adopted children
- •Children without records in the Medical Birth Registry (MBR)
结局指标
主要结局
Autism
时间窗: Children's diagnoses of autism, with follow up beginning at 2 years of age.
ICD-9: 299; ICD-10: F84
ADHD
时间窗: Children's diagnoses of ADHD, with follow up beginning at 2 years of age.
ICD-9: 314; ICD-10: F90; supplemented with methylphenidate \[N06BA04\] or atomoxetin \[N06BA09\] prescriptions registered in the Swedish Prescribed Drug Register
Intellectual Disability
时间窗: Children's diagnoses of intellectual disability, with follow up beginning at 2 years of age.
ICD-9: 317-319 ICD-10: F70-F79
Any Neurodevelopmental Condition
时间窗: Children's diagnoses of neurodevelopmental conditions, with follow up beginning at 2 years of age.
Any diagnosis of Autism, ADHD, or Intellectual Disability
次要结局
- Autism without co-morbidities (ADHD or ID)(Children's diagnoses, with follow up beginning at 2 years of age.)
- Autism with Intellectual Disability(Children's diagnoses, with follow up beginning at 2 years of age.)
- Autism with ADHD(Children's diagnoses, with follow up beginning at 2 years of age.)
- ADHD without co-morbidities (ID or Autism)(Children's diagnoses, with follow up beginning at 2 years of age.)
- Intellectual Disability without Autism(Children's diagnoses, with follow up beginning at 2 years of age.)
研究者
Renee Gardner
Principal Researcher
Karolinska Institutet
